251 related articles for article (PubMed ID: 4197928)
1. Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent.
Streeter DG; Witkowski JT; Khare GP; Sidwell RW; Bauer RJ; Robins RK; Simon LN
Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1174-8. PubMed ID: 4197928
[TBL] [Abstract][Full Text] [Related]
2. In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses.
Huffman JH; Sidwell RW; Khare GP; Witkowski JT; Allen LB; Robins RK
Antimicrob Agents Chemother; 1973 Feb; 3(2):235-41. PubMed ID: 4208281
[TBL] [Abstract][Full Text] [Related]
3. Nuclear magnetic resonance studies of the solution properties of the antiviral nucleoside, 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide, the coresponding 5'-phosphate, and related triazole nucleosides.
Dea P; Schweizer MP; Kreishman GP
Biochemistry; 1974 Apr; 13(9):1862-7. PubMed ID: 4840830
[No Abstract] [Full Text] [Related]
4. Inhibition of vaccinia virus growth by the nucleoside analogue 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ribavirin).
Katz E; Margalith E; Winer B
J Gen Virol; 1976 Aug; 32(2):327-30. PubMed ID: 1018177
[TBL] [Abstract][Full Text] [Related]
5. Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.
Sidwell RW; Huffman JH; Khare GP; Allen LB; Witkowski JT; Robins RK
Science; 1972 Aug; 177(4050):705-6. PubMed ID: 4340949
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of certain 1,2,3-triazole carboxamide nucleosides related to bredinin and pyrazofurin.
Revankar GR; Solan VC; Robins RK; Witkowski JT
Nucleic Acids Symp Ser; 1981; (9):65-8. PubMed ID: 6117831
[TBL] [Abstract][Full Text] [Related]
7. The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin.
Robins RK; Revankar GR; McKernan PA; Murray BK; Kirsi JJ; North JA
Adv Enzyme Regul; 1985; 24():29-43. PubMed ID: 2872781
[TBL] [Abstract][Full Text] [Related]
8. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
Sokoloski JA; Blair OC; Sartorelli AC
Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of subacute sclerosing panencephalitis virus by the antiviral agent ribavirin.
Murphy MF
J Infect Dis; 1978 Aug; 138(2):249-51. PubMed ID: 79625
[TBL] [Abstract][Full Text] [Related]
10. Inosine 5'-monophosphate dehydrogenase of Escherichia coli K12: the nature of the inhibition by guanosine 5'-monophosphate.
Lambden PR; Drabble WT
Biochem J; 1973 Jul; 133(3):607-8. PubMed ID: 4354743
[TBL] [Abstract][Full Text] [Related]
11. Suppression by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) of influenza virus-induced infections in mice.
Khare GP; Sidwell RW; Witkowski JT; Simon LN; Robins RK
Antimicrob Agents Chemother; 1973 Apr; 3(4):517-22. PubMed ID: 4790606
[TBL] [Abstract][Full Text] [Related]
12. Antivirally active ribavirin analogues--4,5-disubstituted 1,2,3-triazole nucleosides: biological evaluation against certain respiratory viruses and computational modelling.
Krajczyk A; Kulinska K; Kulinski T; Hurst BL; Day CW; Smee DF; Ostrowski T; Januszczyk P; Zeidler J
Antivir Chem Chemother; 2014 Jan; 23(4):161-71. PubMed ID: 23538746
[TBL] [Abstract][Full Text] [Related]
13. In vitro effect of virazole against influenza viruses.
Togo Y
Antimicrob Agents Chemother; 1973 Dec; 4(6):641-2. PubMed ID: 4793883
[TBL] [Abstract][Full Text] [Related]
14. Increased sensitivity to oxanosine, a novel nucleoside antibiotic, of rat kidney cells upon expression of the integrated viral src gene.
Uehara Y; Hasegawa M; Hori M; Umezawa H
Cancer Res; 1985 Nov; 45(11 Pt 1):5230-4. PubMed ID: 2413989
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
Franchetti P; Grifantini M
Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
[TBL] [Abstract][Full Text] [Related]
16. Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals.
Sidwell RW; Allen LB; Khare GP; Huffman JH; Witkowski JT; Simon LN; Robins RK
Antimicrob Agents Chemother; 1973 Feb; 3(2):242-6. PubMed ID: 4790589
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides.
Witkowski JT; Robins RK; Sidwell RW; Simon LN
J Med Chem; 1972 Nov; 15(11):1150-4. PubMed ID: 4347550
[No Abstract] [Full Text] [Related]
18. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
Ölschläger S; Neyts J; Günther S
Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
[TBL] [Abstract][Full Text] [Related]
20. Failure of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) to stimllate interferon.
Allen LB; Huffman JH; Sidwell RW
Antimicrob Agents Chemother; 1973 Apr; 3(4):534-5. PubMed ID: 4790608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
